3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine

We are 3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine CAS:401564-36-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine
CAS.NO:401564-36-1
Synonyms:(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
2-Methyl-2-propanyl (2S)-4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)-1-pyrrolidinecarboxylate
(S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate
Molecular Formula:C13H20N2O4S
Molecular Weight:300.37400
 
Specification:
Appearance:White powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Teneligliptin
 
Note:The product under valid patents will not be offered to the countries covered by patents.

3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine


Related News: “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.2-[3-(4-nitrophenyl)propylamino]ethanol Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.2-Bromo-3-methylbutyric acid Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.10,10-Dimethylanthrone Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.For example, an active ingredient to relieve pain is included in a painkiller.

Related Products
Product Name
L-TYROSINE View Details
4-[2-[2-(4-aminophenoxy)ethyl-methylamino]ethyl]aniline View Details
(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid View Details
Z-GLY-PRO-PHE-PRO-LEU-OH manufacturer Diethyl [(2-chloroethoxy)methyl]phosphonate manufacturer Hexanedione manufacturer 3-Chloro-2-Fluorobenzyl Bromide manufacturer 4,5-dibromo-1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-one manufacturer